Podcasts about Mayo Clinic

Get Myo Relax and Calm by Myoscience (20% off, code auto applied): https://bit.ly/4oWU62X  Pre-order Keto Flex Revised and get free bonuses at: https://bit.ly/4wKG1sM    You can fast, do keto, count calories, and hit the gym, and still wake up stuck with the same belly fat. The reason is almost never your daytime effort. It is what happens after your head hits the pillow. Every night your body asks one question: is it safe to burn fat? About 70 percent of your fat burning growth hormone is released while you sleep, but only if insulin is low and your deep sleep is protected. In this lesson, Ben Azadi walks through the three bedtime habits, in the exact order your body wants them, to make the next 30 nights work for your fat loss instead of against it. Key takeaways: Insulin can stay elevated three to five hours after eating, blocking your overnight growth hormone pulse In a crossover trial, a 10 p.m. dinner reduced overnight fat burning and raised cortisol versus the identical 6 p.m. meal A Mayo Clinic trial showed four hours of sleep for two weeks added 11% more visceral fat, while the scale barely moved A cold (65 to 68°F), pitch dark room and a consistent sleep and wake schedule protect deep sleep Relaxation is chemistry: myo-inositol, magnesium glycinate, potassium glycinate, glycine, taurine, GABA, and L-theanine support it The three night challenge: no late snacks, a dark cool room, and track sleep, cravings, waist, and morning energy Find All The Ben Azadi Show Sponsorship Deals ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.ketokamp.com/sponsorship-deals Learn more about your ad choices. Visit megaphone.fm/adchoices

How can therapists avoid the "diagnosis-as-identity" trap with neurodivergent clients?  Working with autistic clients can feel incomplete at times. Newer clinicians or those who aren't neurodivergent may struggle with the dynamics of this unique client/therapist alliance, even as they collaborate on issues related to relationships and empathy. But one autistic psychotherapist and Mayo Clinic researcher urges trauma-informed therapists to stick with this population. He notes that the tools they already use with neurotypical people can also support neurodivergent clients, building capacity for deeper explorations of identity, behavior, and connection in a non-pathologizing environment.  Host Emily Ruth welcomes Dr. Sean Inderbitzen, DSW, LCSW, a psychotherapist, researcher, and author who has dedicated his practice to advancing autism therapy through innovative, evidence-based approaches. The conversation explores ways clinicians can help neurodivergent clients avoid the "diagnosis-as-identity" trap, focusing instead on what is within their control. And finally, Sean guides our audience through a simple yet effective practice for reclaiming a sense of safety and well-being during periods of dysregulation. Transforming Trauma is grateful to Sean for sharing his experiential point of view and for preparing our audience to better support the neurodivergent community.  To read the full show notes and discover more resources, visit https://complextraumatrainingcenter.com/transformingtrauma SPACE: SPACE is an Inner Development Program of Support and Self-Discovery for Therapists on the Personal, Interpersonal, and Transpersonal Levels offered by the Complex Trauma Training Center. This experiential learning program offers an immersive group experience designed to cultivate space for self-care, community support, and deepening vitality in our professional role as therapists. Learn more about how to join. *** The Complex Trauma Training Center: https://complextraumatrainingcenter.com View upcoming trainings: https://complextraumatrainingcenter.com/schedule/ Join us for this a transformative 2-day Intro to NARM® online workshop: https://bit.ly/narmintro *** The Complex Trauma Training Center (CTTC) is a professional organization providing clinical training, education, consultation, and mentorship for psychotherapists and mental health professionals working with individuals and communities impacted by Adverse Childhood Experiences (ACEs) and Complex Trauma (C-PTSD). CTTC provides NARM® Therapist and NARM® Master Therapist Training programs, as well as ongoing monthly groups in support of those learning NARM. CTTC offers a depth-oriented professional community for those seeking a supportive network of therapists focused on three levels of shared human experience: personal, interpersonal & transpersonal. The Transforming Trauma podcast embodies the spirit of CTTC – best described by its three keywords: depth, connection, and heart - and offers guidance to those interested in effective, transformational trauma-informed care. We want to connect with you! Facebook @complextraumatrainingcenter Instagram @cttc_training LinkedIn YouTube

Host: Darryl S. Chutka, M.D.  Guest: Joshua M. Romero, M.D.  Pickleball has become one of the fastest growing sports in the U.S., especially among older adults. This rapid rise in popularity has also resulted in a significant number and variety of sports-related injuries. It's important for primary care clinicians to recognize the most common injuries and their risk factors. We should also discuss preventive strategies with our patients to reduce their risk of injury. Is pickleball so dangerous or do the many injuries result from the popularity of the sport? What health conditions often seen in older individuals place them at increased risk of injury? What are some practical preventive strategies we can recommend to our patients who are planning to start playing the sport? I'll get answers to these questions from my guest, Dr. Joshua Romero, a sports medicine physician in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Differential Diagnosis and Workup of Thoracic Aortic Aneurysm   Guest: Juan M. Bowen, M.D. Host: Malcolm R. Bell, M.D.   Thoracic aortic aneurysms are often found as incidental findings on imaging done for other indications.  In this episode, listeners will learn more about the approach the Mayo Clinic Marfan and Thoracic Aorta Clinic takes. We can often find the cause by taking a directed family history and personal history, by looking for key physical findings, and by obtaining appropriate imaging and often also genetic tests.   Topics Discussed: What is the differential diagnosis in adult patients? What questions are most helpful in the patient history, and what physical findings should the examiner look for? What cardiac and vascular imaging should be done on the initial evaluation? When should genetic tests be considered? When should preventive aortic repair be considered?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 14-January-2026

-Discover how to move your IRA or 401k into physical gold and silver — with no taxes or penalties. Get your free portfolio review and free gold & silver guide from GoldenCrest Metals: visit https://GoldenCrestMetals.com/thewhyfiles or call (888) 949-9172 now. -Start your risk-free Greenlight trial today at https://greenlight.com/why to teach your kids real-world money skills. -Elevate your summer wardrobe—go to https://quince.com/thewhyfiles for free shipping on your order and 365-day returns (now available in Canada). -Sign up for therapy and get 10% off at https://betterhelp.com/whyfiles . #ad In May 1967, a Polish immigrant named Stefan Michalak was hunting for silver in the Canadian wilderness when two glowing objects dropped out of the sky. One landed nearby. He sketched it, approached it, and ended up in the hospital. His burns were documented. His weight loss was documented. His radiation-like symptoms baffled more than a dozen doctors, including specialists at the Mayo Clinic. The Royal Canadian Air Force launched an investigation. So did the RCMP. So did the US Air Force. Nobody could explain what happened. The government eventually sealed the file. The same government, fifty years later, minted his story on a coin. It glows in the dark. This is the Falcon Lake Incident — Canada's most documented UFO case, and it's still unsolved. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Host: Darryl S. Chutka, M.D.  Guest: Stacey Rizza, M.D.  Although vector-borne illnesses can be acquired by travel to distant parts of the world, some can be acquired here in the U.S. As a result, these infections become pertinent to primary care clinicians as they can produce serious complications. When should we suspect a vector-borne illness in a patient? How do we distinguish it from other viral syndromes? What are some of the serious complications that can occur? In today's podcast, we'll be discussing three vector-borne illnesses including Zika virus, West Nile virus, and Dengue Fever. My guest is an infectious disease specialist, Dr. Stacey Rizza from the Mayo Clinic as we discuss “Vector-Borne Illnesses”.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Dr. Eden Biltibo is a Hematology/Oncology clinical fellow at Vanderbilt University Medical Center in Nashville, TN.Dr. Camille V. Edwards is a board-certified primary care physician at Boston Medical Center (BMC) and an Assistant Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine.Dr. Joselle Cook is a hematologist/oncologist at the Mayo Clinic in Rochester, Minnesota, where she specializes in dysproteinemia, plasma cell disorders, and precursor conditions.THIS PODCAST IS BROUGHT TO YOU IN PARTNERSHIP WITH THE MULTIPLE MYELOMA RESEARCH FOUNDATION.

In this special edition of our Everyday Heroes series, Music Matters host Darrell Craig Harris sits down with longtime friend Nicole Kavanaugh—an inspiring advocate whose life has been defined by compassion, service, and giving back. Nicole shares her remarkable journey as an organ donor advocate and St. Jude Children's Research Hospital Ambassador, discussing the profound impact that organ donation can have on individuals, families, and entire communities. Through her personal experiences, she demonstrates how one person can make a lasting difference in the lives of others. This heartfelt conversation celebrates the power of generosity, hope, and the everyday heroes who quietly change the world around them. Learn More St. Jude Children's Research Hospital Website: www.StJude.org Research Hospital 7 Phone: (800) 822-6344 Mayo Clinic Transplant Center Website: www.MayoClinic.org  Phone: (866) 227-1569 National Kidney Foundation www.Kidney.org Nicole Kavanaugh St. Jude sponsorship page https://fundraising.stjude.org/site/TR?px=4712745&fr_id=164588&pg=personal 2026 St. Jude Memphis Marathon Weekend: If you'd like to learn more about becoming an organ donor, supporting transplant patients, or helping children battling catastrophic illnesses, please visit the organizations above for information and resources. About Music Matters with Darrell Craig Harris The Music Matters Podcast is hosted by Darrell Craig Harris, a globally published music journalist, professional musician, and Sports Illustrated photographer. Music Matters is now available on Spotify, iTunes, Podbean, and more. Each week, Darrell interviews renowned artists, musicians, music journalists, and insiders from the music industry. Currently, over 1.2 million global downloads in 40 countries. Visit us at: www.MusicMattersPodcast.com Follow us on Twitter: www.Twitter.com/musicmattersdh  Instagram: www.Instagram.com/musicmatterspodcastofficial For inquiries, contact: musicmatterspodcastshow@gmail.com Support our mission via PayPal: www.paypal.me/payDarrell  Voice intro by Nigel J. Farmer of Voice Wrap Studios Representation:  Yvette Morales | YM & Associates PR Beverly Hills, CA YM-PR.com Email: YMoralesY@ym-pr.com                        

This Men's Health Month, Navigating Cancer TOGETHER sits down with Clarence Jones, prostate cancer survivor and one of Minnesota's most trusted names in community health.Clarence Jones, MA, CHW, CPH, CPE, is the Executive Director and Community Health Strategist of the Hue-MAN Partnership, a founding member of the organization he helped build into one of Minnesota's most trusted voices in public health. He serves as an Adjunct Instructor of Medicine at Mayo Clinic, is a founding member of the Minnesota Fathers and Families Network, has served as the Mayor's Representative and co-chair of the Public Health Advisory Committee for the City of Minneapolis, and holds affiliations with the CTSI Executive Leadership team and the University of Minnesota's CEARCH initiative. He is also a fatherhood doula, the host of the Community Health Dialogue radio show on KMOJ 89.9 FM, and co-host of the Health Chatter podcast.In this warm, honest, and personal conversation, Clarence opens up about his own journey through prostate cancer, from watching his PSA numbers climb year after year and practicing watchful waiting, to eventually choosing surgery. He shares why the digital exam scares men, and why early detection is the greatest gift you can give your family.But Clarence's story doesn't stop at survival. He shares how his experience deepened his mission to make sure the men and families in his community have access to credible, culturally relevant, evidence-based health information. That's the heartbeat of everything Hue-MAN does.You'll also hear him talk about what he wants every man facing a cancer diagnosis to know right now.✨ Episode Highlights:00:04:38 The Moment He Knew: Clarence's Prostate Cancer Journey00:09:22 How to Invite Men into Health Conversations Without Lecturing Them00:14:44 What Young Men Need to Know About PSA Screening and Biopsies00:27:45 Fatherhood Doula: What That Means and Why Fathers Matter00:36:55 What 'Navigating Cancer TOGETHER' Really MeansTranscript: https://bit.ly/podscript184Connect & Engage with ClarenceWebsite: www.huemanpartnershipalliance.orgHealth Chatter Podcast: www.healthchatterpodcast.comKMOJ Community Health Dialogue: 89.9 KMOJ FM

Host: Darryl S. Chutka, M.D.  Guest: Stacey Rizza, M.D.  Lyme Disease is a tick-borne illness commonly seen in various parts of the country. Despite its common occurrence in the primary care practice, it's associated with confusion and controversy. From the presenting symptoms, occasional ambiguous serologic results, to managing patients with persistent symptoms following treatment, primary care clinicians are often frustrated with the management of patients who have or are concerned they have Lyme Disease. In today's podcast, we'll discuss what we know about Lyme Disease, what's still uncertain, and how we should approach this health problem in our patients. Joining me for this podcast is Dr. Stacey Rizza, an infectious disease specialist at the Mayo Clinic.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development

Dealing with the Latest Financial Trend: Spending Your Kids' Inheritance Episode 388 – Financial trends come and go, but the latest, “SKI,” or Spending Kids' Inheritance, is likely to have a lasting impact. Are you prepared? There are some ways to learn how to “SKI” without getting hurt. More SML Planning Minute Podcast Episodes Transcript of Podcast Episode 388 Hello, this is Bill Rainaldi, with another edition of Security Mutual's SML Planning Minute. In today's episode, dealing with the latest financial trend: spending your kids' inheritance. Have you heard of the latest movement in personal finance? It's called “SKI,” or “Spending Kids' Inheritance.” Not surprisingly, it can create conflict across generations. It wasn't that long ago that people commonly followed the same financial plan: save money during your high earning years, spend carefully during retirement, and leave a decent inheritance for your kids so that they can live a better life than you did. But according to a recent article in Kiplinger, those plans are changing. Rather than focusing on what they'll eventually leave behind, more people are trying to spend their money while they’re still here to enjoy it. Today, new retirees are spending more on experiences, including “bucket list” travel.[1] In many ways, it's simply recognizing that your health, longevity and energy levels are going to run out someday, and maybe it's best to experience some fun while you still have the chance. And it's having an effect on the travel industry. The trend has become noticeable enough that it's “beginning to reshape how affluent travelers are spending their money on luxury travel.”[2] It's understandable why this is happening. As we've documented in previous episodes, longevity is on the rise. But there's also evidence to suggest that healthspans aren't keeping up. Healthspan can be defined as the number of years a person lives a “healthy, active, disease-free life.”[3] Research by the World Health Organization indicates that there's a growing disparity between lifespan and healthspan. The average gap between lifespan and healthspan is estimated at approximately 12.5 years in the United States, which is 13 percent higher than it was in the year 2000. In other words, over time, people are gaining extra years of life faster than they are gaining years of good health.[4] Perhaps one other reason for the upswing in SKI is that a surprising number of heirs end up wasting their inheritance. According to a recent survey by Texas Tech University and the University of Alabama, a substantial portion of heirs spend all of their inheritance in the first year. By then, a full 42 percent had seen their net worth drop back to or below what it had been before the inheritance.[5] As one of the authors wrote, “This propensity to immediately spend the entire inheritance is high. In fact, it's higher than with ANY OTHER type of financial windfall (when controlling for windfall size).” There are certainly some risks built into the SKI trend. For one thing, if you're not careful, you could easily spend your own retirement savings too quickly and be forced to adjust to a lower standard of living. And so many people underestimate the eventual cost of health care and long-term care. Also, it's easy to let small upgrades in your lifestyle add up to a much bigger problem later on, a phenomenon known as “lifestyle creep.” Kiplinger goes on to suggest some ideas for how to SKI intelligently. First, you need to set a baseline. Not for what you want to spend, but for what you want to keep. This should help maintain some peace of mind for both you and your heirs.[6] Next, they suggest doing some extra budgeting when it comes to travel. Make travel a specific factor in your overall retirement plan. The author also feels that a bucket list trip doesn't have to be to an exotic place on the other side of the world. It just has to be meaningful. In the long run, a memorable shared experience while you're living can have a greater impact than a bigger inheritance.[7] And finally, maybe you can still make some gifts to your heirs from time to time. The belief is that a smaller financial gift, at the right time, can have an oversized impact. So can bringing some of your heirs along with you on some of your trips. The memory might end up being more important than the money.[8] An important question remains, however: how to deal with SKI? There's one potential solution they fail to mention: life insurance. It's there to provide that extra cushion. If you've got enough of it, you can feel free to spend a good chunk of your kids' inheritance without much guilt. It's as if you've addressed the inheritance part prior to your retirement spending. Purchasing life insurance, and early, can be one of those instances where you really can get the best of both worlds during your working years and in retirement. And as you probably realize, the older you get, the higher life insurance premiums become. So, the sooner you start, the better. Do you have enough life insurance that your heirs will be OK if you decide to go “Skiing?” Your Security Mutual Life insurance agent can help. Your Security Mutual Life insurance agent will augment or assemble your team and coordinate with your attorney and tax professional to review your situation and to determine the insurance plan that will best suit your needs and objectives. [1] Maddox, Choncé. “The SKI Travel Trend Is Reshaping Retirement Spending.” Kiplinger.com. https://www.kiplinger.com/personal-finance/travel/ski-retirement-travel-trend (accessed April 28, 2026). [2] Kompanik, Noreen. “The SKI trend that's reshaping travel.” GMtoday.com. https://www.gmtoday.com/travel/the-ski-trend-that-s-reshaping-travel/article_07ca7b72-0eb4-43fc-b8ec-e69fef82a694.html (accessed April 29, 2026). [3] Buckles, Susan. “The global divide between longer life and good health.” Mayoclinic.org. https://newsnetwork.mayoclinic.org/discussion/the-global-divide-between-longer-life-and-good-health/ (accessed April 28, 2026). [4] Borst, Heidi. “Longevity In The U.S.: The Gap Between Lifespan and Health Span.” Forbes.com. https://www.forbes.com/health/wellness/longevity-life-expectancy/ (accessed April 28, 2026). [5] Brin, Dinah Wisenberg. “Heirs Beware: 42% Spend Inheritance Within a Year, Study Finds.” Thinkadvisor.com. https://www.thinkadvisor.com/2026/04/07/heirs-beware-42-spend-inheritance-within-a-year-study-finds/ (accessed April 28, 2026). [6] Maddox, Choncé. “The SKI Travel Trend Is Reshaping Retirement Spending.” Kiplinger.com. https://www.kiplinger.com/personal-finance/travel/ski-retirement-travel-trend (accessed April 28, 2026). [7] Id. [8] Id. More SML Planning Minute Podcast Episodes This podcast is brought to you by Security Mutual Life Insurance Company of New York, The Company That Cares®. The content provided is intended for educational and informational purposes only. Information is provided in good faith. However, the Company makes no representation or warranty of any kind regarding the accuracy, reliability, or completeness of the information. The information presented is designed to provide general information regarding the subject matter covered. It is not to serve as legal, tax or other financial advice related to individual situations, because each individual's legal, tax and financial situation is different. Specific advice needs to be tailored to your situation. Therefore, please consult with your own attorney, tax professional and/or other advisors regarding your specific situation. To help reach your goals, you need a skilled professional by your side. Contact your local Security Mutual life insurance advisor today. As part of the planning process, he or she will coordinate with your other advisors as needed to help you achieve your financial goals and objectives. For more information, visit us at SMLNY.com/SMLPodcast. If you've enjoyed this podcast, tell your friends about it. And be sure to give us a five-star review. And check us out on LinkedIn, YouTube and Twitter. Thanks for listening, and we'll talk to you next time. Tax laws are complex and subject to change. The information presented is based on current interpretation of the laws. Neither Security Mutual nor its agents are permitted to provide tax or legal advice. The applicability of any strategy discussed is dependent upon the particular facts and circumstances. Results may vary, and products and services discussed may not be appropriate for all situations. Each person's needs, objectives and financial circumstances are different, and must be reviewed and analyzed independently. We encourage individuals to seek personalized advice from a qualified Security Mutual life insurance advisor regarding their personal needs, objectives, and financial circumstances. Insurance products are issued by Security Mutual Life Insurance Company of New York, Binghamton, New York. Product availability and features may vary by state.​ SubscribeApple PodcastsSpotifyAndroidPandoraby EmailTuneInDeezerRSSMore Subscribe Options

A severe blockage in the "widowmaker" artery sounds like an automatic trip to the cath lab but is it always? In this episode, Dr. Robert Todd Hurst, MD, FACC, FASE shares a remarkable real-world case that challenges conventional thinking about stents and heart disease treatment. He explains the difference between stable and unstable coronary artery disease, reviews the research behind stents versus aggressive medical therapy, and reveals how one patient with a severe LAD blockage improved his artery health without undergoing an invasive procedure. You'll also learn why understanding root causes, optimizing risk factors, and taking a personalized approach to prevention may be more important than many people realize. About Dr. Robert Todd Hurst, MD, FACC, FASE Dr. Robert Todd Hurst, MD, FACC, FASE is a board-certified preventive cardiologist, former Mayo Clinic physician, and founder of HealthspanMD. His mission is simple: that no one dies of a heart attack, ever. Through a proactive, precision-medicine approach, he helps patients identify hidden cardiovascular risk, reverse heart disease, and add strong, vital, mentally sharp years to life. In this podcast, he shares practical insights from more than two decades of experience helping people prevent and overcome cardiovascular disease. Key Timestamps 00:00 – Introduction: Do severe blockages always require a stent? 00:27 – Case study: A patient with a severe LAD ("widowmaker") blockage and no symptoms 01:14 – Why stress testing, echocardiograms, and symptoms matter when evaluating blockages 01:39 – What research shows about stents versus aggressive medical therapy for stable coronary artery disease 02:46 – The real risks of angiograms, stents, and invasive procedures 03:36 – Why the patient's condition did not automatically justify a stent 04:15 – Optimizing cholesterol, insulin resistance, and other root causes 04:42 – One year later: Severe blockage improves to moderate stenosis 05:04 – Evidence of plaque regression and why the results matter 05:35 – How cardiology thinking has evolved since the COURAGE trial 06:07 – When stents and bypass surgery may still be the right choice 06:41 – Questions every patient should ask before agreeing to a stent 07:02 – Long-term considerations and risks of living with a stent 07:20 – Why healthcare remains reactive instead of preventive 07:47 – HealthspanMD's mission: Moving from disease treatment to health optimization 08:08 – Final thoughts and invitation to learn more about HealthspanMD 08:34 – Medical disclaimer This episode is for educational purposes only and should not be considered medical advice. Always discuss treatment decisions with your healthcare provider. This information is for educational purposes only and is not medical advice. Don't make any decisions about your medical treatment without first talking to your doctor. Connect* with HealthspanMD :

Send us Fan MailCommon questions about fasting Most common questions•What is intermittent fasting?•What is the best fasting schedule, like 16:8 or 5:2?•Can it help with weight loss?•What am I allowed to drink during the fasting window?•Will it hurt energy, focus, or workouts?•Is it safe for everyone?•Does it matter what I eat when I do eat?•How long does it take to see results?•Can I do it every day?•What are the side effects or risks?What people worry about most:  A lot of the concern is about whether fasting is actually healthy, whether the benefits last, and whether it is just another calorie-cutting strategy in disguise. Mayo Clinic notes that some short-term improvements have been seen in blood sugar, weight, cholesterol, blood pressure, and inflammation, but long-term effects are still unclear. MedlinePlus also highlights that what and how much you eat still matter, not just the timing

The Central Role of Cardiac MRI in the Management of Heart Failure and Cardiomyopathy Patients   Guest: Gosia Wamil, M.D., Ph.D. Host: Malcolm R. Bell, M.D.   Cardiac MRI is now central to heart failure care, moving beyond imaging to guide diagnosis and treatment. It distinguishes disease causes, identifies fibrosis and scar, and uncovers specific conditions in both HFrEF and HFpEF. By providing prognostic markers, it helps tailor therapies and improve outcomes—delivering the right treatment at the right time. In this episode of "Interviews With the Experts," Dr. Malcolm Bell interviews Dr. Gosia Wamil from Mayo Clinic London practice on the role of cardiac MRI in practice.   Topics Discussed: When does CMR change the management decision? CMR findings Which CMR biomarkers truly predict outcomes—and how should clinicians act on them? From echo-first to CMR-led pathways: what should every HF service implement now?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 14-January-2026  

Myoscience Creatine with 20% off: https://bit.ly/43EWGRc   Pre-order Keto Flex Revised and get free bonuses at: https://bit.ly/4wKG1sM    I'm 41 and I Feel Younger Than I Did at 25. The 5 Exercises Behind It. People who can lower themselves to the floor and stand back up cleanly have a roughly 3 to 4% risk of dying in a given follow-up period. People who struggle? 42%. That's the kind of longevity signal no blood test or gadget can match, and you can run it in your living room in 10 seconds. In this episode, I share the five exercises that have helped me feel genuinely younger at 41 than I did at 25. Not because of genetics or living in the gym, but because I stopped letting critical movements disappear. Each one targets a specific ability that fades first: energy, mobility, strength, power, and the single movement that predicts long-term independence. I also share the Mayo Clinic study on mitochondria and HIIT that showed older bodies responding more than younger ones to training, why power declines almost twice as fast as strength after 40, and the personal moment with my German Shepherd Ziggy that forced me to take hip hinge strength seriously. Key Takeaways: Most people don't get old first. They get weak first. Accelerated aging is driven by the movements you stop practicing. Mayo Clinic research showed older adults boosted cellular energy capacity by 69% on HIIT, compared to 49% in younger adults. Power (force produced quickly) fades nearly twice as fast as strength after 40, and people with low power have nearly 6x the risk of dying. The sit-to-stand floor test separates a 3 to 4% mortality risk from a 42% one. It tests everything, leg strength, mobility, balance, and coordination, in one movement. Single-leg balance for 10 seconds is one of the most sensitive aging signals available and almost nobody is checking it. After age 30, natural creatine production declines, making recovery, strength, and brain function harder to maintain without supplementation. Find All The Ben Azadi Show Sponsorship Deals ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.ketokamp.com/sponsorship-deals Learn more about your ad choices. Visit megaphone.fm/adchoices

You could be eating well, supplementing intentionally, and doing all the "right" things and still be quietly working against yourself every single day. Not because of what you're not doing, but because of what you're putting in and on your body without realizing it. Nobody told us either, until someone who loved us did. Now we're telling you.This episode is a swap episode. Six things, three from Brandi and three from Dr. Desiree, that we have personally changed in our own lives. Not from a place of panic, but from a place of having the information and making the obvious next move. The science on what's in conventional cookware, makeup, lotion, and coffee isn't obscure. The product industry just hasn't had much incentive to share it. We do.Brandi walks through her swaps from body butter to wooden kitchen utensils to a blood-sugar-stable chocolate bar that actually tastes like a chocolate bar. Dr. Desiree covers the research on non-stick cookware and forever chemicals, the fragrance loophole hiding in your makeup bag, and what's really in most commercial coffee. None of these swaps require blowing up your life. Most of them cost the same or less than what you're already using.What You'll Learn:Why the first ingredient on most conventional lotions is water and what that means for your skin barrierWhat Chaga's ORAC value actually is and why applying antioxidants topically to inflamed or psoriatic skin has a real mechanism behind itWhat happens when a plastic or silicone spatula sits in a hot pan (and why "BPA-free" didn't solve the problem)Why monk fruit has a glycemic index of zero and how that changes what happens to your energy an hour after a sweet snackThe PFAS "forever chemicals" in conventional non-stick cookware, what temperature matters, and the simple technique that makes stainless steel actually workThe fragrance loophole in US and Canadian cosmetic labeling that lets one word hide dozens to hundreds of undisclosed compoundsWhy coffee is one of the most heavily pesticide-sprayed crops in the world and how mycotoxins get in before the bag ever reaches your kitchenHow L-theanine in matcha changes the quality of caffeine in the body and why it may matter more for perimenopausal women managing cortisolFour free apps and databases you can use right now to check what's actually in your makeup before you repurchase itResources Mentioned:EWG Skin Deep database (free ingredient safety ratings): https://www.ewg.org/skindeep/Yuka app (scan product barcodes in-store for ingredient scores): https://yuka.io/en/SkinSafe (developed with Mayo Clinic, helpful for sensitive skin): https://www.skinsafe.com/Merit makeup: https://www.meritbeauty.com/Your Next Steps:Follow us on Instagram: https://www.instagram.com/eversiowellness/Shop Eversio Wellness and save 15% with code PODCAST15: https://www.eversiowellness.com/discount/PODCAST15?redirect=%2Fcollections%2Fall-productsNot sure which mushroom is right for you? Take our free quiz: https://www.eversiowellness.com/pages/take-our-quiz

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.PAMA update (00:01): Get the latest on PAMA as the first data collection period begins, including ongoing efforts to advance the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.Policy changes influencing diagnostics (04:09): Learn how evolving reimbursement policies for blood-based cancer screening and a proposed CLIA modernization bill may impact the field.Pharmacogenomic tests improving cancer care (08:14): Discover how pharmacogenomics are benefiting patients with cancer, the benefits of medication-based testing, and how this field is advancing.ResourcesCMS: CLFS & PAMA reporting and resourcesPrecision Oncology Therapeutics: Personalized cancer treatmentAnswers From the Lab: Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.Answers From the Lab: Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

Award-winning journalist Lindsey Seavert is our new host as we explore the innovations changing the landscape of medicine. Featuring conversations with leading physicians, researchers, and medical experts, the new season looks at everything from AI-powered diagnostics and cutting-edge cancer therapies to surgical technologies improving patient care today.Across a new series of in-depth conversations, we explore the breakthroughs that rarely make headlines and the ways medicine continues to evolve. Becoming smarter, more human, and more connected. Whether you are a patient, clinician, or simply curious about where medicine is headed next, Tomorrow's Cure delivers accessible, thought-provoking insights wherever you listen to podcasts.How to listen and stay connected:Subscribe to Tomorrow's Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic's experts—subscribe to Mayo Clinic's newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

You built something successful. Maybe it's a course that sells. Maybe it's a coaching program. Maybe you're the expert on the speaking circuit. You're established. You're making good money. People know who you are. And something feels off. In this episode of The Expert Edge, I sit down with Dr. Larry Daugherty, a radiation oncologist who went from living his "dream career" at Mayo Clinic to realizing he was hollow inside. He made the radical pivot into his actual passion, monetized before it was perfect, and built a thriving community-based business that fulfills him. This conversation is for the established expert who's wondering if there's more to the game. Why your courses aren't selling like they used to. Why community beats information. And how to build a business around what actually matters to you. What you'll learn: → Monetize first, perfect later - Why action beats analysis every time (especially when you're already established) → Higher ticket clients are fundamentally different - The 6X difference in results when you serve premium clients who show up with commitment → Small cohorts demand ruthless selection - Why one person not taking action in a five-person group spreads like a disease (but goes unnoticed in larger groups) → Community is your moat now - Why information is commoditized and belonging is the new currency → The suppressed part of yourself - How successful experts often realize they've buried the part that actually comes alive Real insights from the episode: Larry's story: from Mayo Clinic dream job to feeling hollow inside despite everything he worked for The moment an advertisement for a dog sled race above the Arctic Circle changed his entire trajectory Why he pivoted from courses to building a premium community-based business How he went from $3.5K to $5K to $30K offerings by monetizing before perfecting Why higher ticket clients are easier to work with (and produce 6X better results) The mistake of filling seats instead of selecting carefully in small cohorts How AI has made courses commoditized (and what to do about it) The shift from selling information to selling belonging and community Why the highest level of success requires authenticity and vulnerability   If you're an established coach, consultant, speaker, or course creator who's wondering if there's more to this game, Larry's story is for you. He went from a six-figure career to pivoting into community-based business that actually fulfills him. Check out his work at thefreedomphysician.com to see how he applied these principles. The frameworks work across industries: monetize first, build community, and scale through belonging instead of information. Join our next Speak to Convert Masterclass. In this live workshop, you'll discover how to build and launch a high converting presentation that gets you clients every time you present. https://colinboyd.co/speak Discover how to authentically connect with your audience & fill your programs with a Conversion Story - Version 2.0 (AI Edition) is now available. https://www.conversionstoryformula.com Hit the "Follow" button so you don't miss an episode! Love this podcast? Write a review and give it a 5-star rating!  For all the show notes and links: https://www.expertedgepodcast.com/blog/episode324 Connect with Colin on Instagram: https://www.instagram.com/colinboyd/  

Host: Darryl S. Chutka, M.D.  Guest: Stacey Rizza, M.D.  We've now had our second outbreak of a potentially deadly infectious disease. Hantavirus has been diagnosed in several individuals and most recently just under 100 cases of Ebola Virus have been confirmed along with several hundred suspected cases. Ebola virus is caused by several species of the Ebola Virus and is frequently fatal.  Early symptoms are non-specific and similar to other common viral infections, making an early diagnosis challenging. Who's at risk of acquiring Ebola Virus? How is it spread from person to person? How deadly is the virus and finally, does it have the potential to become our next pandemic?  In this podcast, we're going to learn more about Ebola Virus. My guest is an infectious disease specialist, Dr. Stacey Rizza from the Mayo Clinic.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Anthropic is preparing for public markets. Europe is pushing to reduce its reliance on American tech. And CNN just filed a copyright lawsuit against Perplexity. This week, Anthropic files confidential paperwork for an IPO in one of the biggest milestones yet for the AI industry, Europe unveils a tech sovereignty plan to reduce its dependence on American technology, CNN sues Perplexity over the alleged redistribution of more than 17,000 copyrighted stories, Morgan Stanley opens its platform to external AI agents using MCP, and Microsoft teams up with Mayo Clinic to build an AI model for healthcare. If you are a founder, operator or executive trying to keep up with AI, this is your weekly five minute briefing. Stories Covered This Week: Anthropic files confidential paperwork for an IPO, with OpenAI expected to follow soon Europe unveils a tech sovereignty plan to build out data centers, revive its chip industry and buy more from European suppliers CNN sues Perplexity over the alleged use of more than 17,000 copyrighted stories, photos and videos Morgan Stanley becomes one of the first major Wall Street banks to open its platform to external AI agents via MCP Microsoft and Mayo Clinic partner to build an AI model designed specifically for healthcare Episode Timestamps: 00:00 Intro 00:17 Anthropic files to go public 01:17 Europe pushes for tech sovereignty 02:28 CNN sues Perplexity 03:23 Morgan Stanley opens up to AI agents 04:22 Microsoft and Mayo Clinic build a healthcare AI 05:11 Outro Partner Links: Upgrade your AI toolkit: https://www.theaireport.ai/ai-executive-pass Subscribe to our free newsletter: https://newsletter.theaireport.ai/subscribe Join the community: https://community.theaireport.ai/checkout/the-ai-report-welcome-gift?coupon_code=WRTH Learn more about your ad choices. Visit megaphone.fm/adchoices

AI in Imaging: How Will it Change What We Do   Guest: Tim Poterucha, M.D. Host: Kyle Klarich, M.D.   Artificial intelligence (AI) is beginning to reshape how we acquire, interpret, and act on cardiovascular imaging, particularly echocardiography. In this episode, we'll walk through how we got here—from the historical innovation arc of echo to modern AI tools that segment images, detect disease, and support interpretation—and discuss what is real, what is hype, and where the true clinical opportunities and risks lie. We'll also explore what this means for practicing clinicians and trainees who are considering a future in imaging.   Topics Discussed: When it comes specifically to cardiovascular imaging, what is the current role of AI, and why is imaging such a natural fit for these tools? What are the problems with how we interpret imaging now, and what are the risks of AI? What is hype right now, and what is real? Is AI going to replace cardiologists for medical imaging interpretation, and should cardiology fellows be worried about going into imaging with the rise of AI?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded 01-December-2025

Duct fixes a lot of things, including my comedy career. Ok, not really my career, but the transportation getting me to the gigs. Here's a quick, embarrassing story about my use of duct tape. Not really looking my best as I drove around the country, but it ws functional . . .for a while.  https://www.TheWorkLady.com  Jan McInnis is a top change management keynote speaker, comedian, and funny motivational speaker who helps organizations use humor to handle change, build resilience, and strengthen leadership skills. With her laugh-out-loud stories and practical tips, Jan shows audiences how humor isn't just entertainment—it's a business skill that drives communication, connection, and stress relief. A conference keynote speaker, Master of Ceremonies, and comedy writer, Jan has written material for The Tonight Show with Jay Leno as well as radio, TV, and syndicated cartoon strips. She's the author of two books—Finding the Funny Fast and Convention Comedian—and her insights on humor in business have been featured in The Wall Street Journal, The Washington Post, and The Huffington Post. For over 25 years, she has been helping leaders and teams discover how to bounce back from setbacks, embrace change, and connect through comedy. Jan has delivered keynote speeches at thousands of events nationwide, from the Federal Reserve Banks to the Mayo Clinic, for industries that include healthcare, finance, government, education, women's leadership events, technology, and safety & disaster management. Her client list features respected organizations such as: Healthcare: Mayo Clinic, Kaiser Permanente, Abbott Pharmaceuticals, Health Information Management Associations, Assisted Living Associations Finance: Federal Reserve Banks, Merrill Lynch, Transamerica Insurance, BDO Accounting, American Institute of CPAs, credit unions, banking associations Government: U.S. Air Force, Social Security Administration, International Institute of Municipal Clerks, National League of Cities, public utilities, correctional associations Women's Leadership Events: Toyota Women's Conference, Go Red for Women, Speaking of Women's Health, Soroptimists, Women in Insurance & Financial Services Education: State superintendent associations, community college associations, Head Start associations, National Association of Elementary and Middle School Principals Safety & Disaster: International Association of Emergency Managers, Disney Emergency Management, Mid-Atlantic Safety Conference, risk management associations   Her background as a Washington, D.C. marketing executive gives her a unique perspective that blends business acumen with stand-up comedy. Jan was also honored with the Greater Washington Society of Association Executives "Excellence in Education" Award. Along with her podcast Finding the Funny: Leadership Tips from a Comedian, Jan also produces Comedian Stories: Tales From the Road in Under 5 Minutes. Whether she's headlining a major convention, hosting a leadership retreat, or teaching resilience at a safety conference, Jan's programs give audiences the tools to laugh, learn, and lead.  

Get Myoscience Creatine and Magnesium (20% off) HERE: https://bit.ly/4ocjMbp  Pre-order Keto Flex Revised and get free bonuses: https://bit.ly/4wKG1sM    Men today are walking around with 20 to 30% less testosterone than their fathers had at the exact same age. Not because of disease. Because of five everyday habits that modern men think are completely normal. In this episode, I'm breaking down the five silent mistakes that are aging men faster than anything else right now, the science behind why they're so damaging, and the exact daily stack I personally use to fight back. I'm 41 years old and I've watched this happen to men I love. The decline doesn't announce itself. But it can be reversed. Key Takeaways: Men today have 20 to 30% less testosterone than men of the same age in 1988, per the Massachusetts Male Aging Study Grip strength predicts death more accurately than blood pressure, per a Lancet meta-analysis of 140,000 people One week of sleeping 5 hours or less drops testosterone by 10 to 15%, the equivalent of aging 10 to 15 years Sitting for long hours thins the memory center of the brain, and exercise does not offset this damage 85-year-olds gained muscle and reversed fiber-level aging in 12 weeks of resistance training in a Mayo Clinic study The five mistakes: stopping explosive movement, stopping brain challenges, ignoring muscle decline, neglecting recovery, and accepting decline as normal The simple daily stack: outdoor walks, heavy lifting twice a week, one gram of protein per pound of ideal body weight, 7+ hours of sleep, creatine, magnesium, and weekly brain challenges Find All The Ben Azadi Show Sponsorship Deals ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.ketokamp.com/sponsorship-deals Learn more about your ad choices. Visit megaphone.fm/adchoices

Moderator: Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison) Guests · Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester · Dr. François Codère Associate Professor from the Université de Montréal in Canada · Dr. Richard Allen, Professor at Baylor in Texas   In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected? Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.

If you're on a GLP-1 and nobody told you how to eat on it, this one's for you. We get into it in depth.Andrea Donsky, nutritionist, bestselling author of Nourishing Menopause, 7x published menopause researcher, menopause educator, and co-founder of wearemorphus.com, sits down with nutrition and fitness coach Natalie Bean, who is GLP-1 certified and has spent 31 years helping people change how they eat. If you're taking Ozempic, Mounjaro, or Wegovy, thinking about it, or you just want to take back control with food, Natalie walks through what actually protects your body. Spoiler: protein is not optional, and the scale is not the whole story.What you'll learn:Why a GLP-1 can cost you 25 to 40 percent of your weight as muscle, and how to push back with foodHow much protein women in perimenopause and menopause really need (and why it climbs on a GLP-1)Whether you'll gain the weight back when you stop, and what a maintenance dose actually doesThe GLP-1 side effects nobody warns you about, from dry mouth to constipation to brittle bonesWhy cardio is not the enemy, and where strength training and cortisol fit inChapters0:00 GLP-1 and muscle loss: the Mayo Clinic stat that stopped me0:48 Meet Natalie Bean and who GLP-1 meds are really for4:45 Food noise, sugar cravings, and insulin resistance after 409:45 Do you gain the weight back after stopping a GLP-1?14:10 How much protein you actually need on a GLP-119:40 GLP-1 side effects: dry mouth, digestion, bones, dehydration25:10 Fiber, constipation, and eating every 2 to 3 hours30:10 Why consistency beats variety when you start over35:10 Cortisol, cardio vs strength, and non-negotiable supplementsListen to this next:Tired of Fighting Food Cravings? Try This Instead: https://youtu.be/2PQxAbnll8sWork with Natalie: https://nutritionforeverinc.com/Send us Fan Mail ======Morphus: Menopause Reimagined

In this episode of the Brain & Life Podcast, co-host Dr. Katy Peters is joined by novelist and disability advocate Sabina Nordqvist. Sabina discusses her personal 12-year battle with idiopathic intracranial hypertension (IIH), POTS, and Ehlers-Danlos syndrome. She shares the profound impact of misdiagnosis, the importance of self-advocacy, and how her experiences in support groups led her to write a novel called It's All in Your Head that puts disabled characters front and center. Dr. Peters is then joined by Dr. Jeremy Cutsforth-Gregory, an Assistant Professor of Neurology at Mayo Clinic in Rochester, Minnesota, working in the Division of Neurologic Education. Dr. Cutsforth-Gregory explains cerebrospinal fluid and IIH, highlighting the treatments that are available and where research is going next.   Additional Resources Sabina Nordqvist- It's All in Your Head Understanding the Mysteries of POTS and Other Autonomic Disorders A Swimmer Returns to the Pool After Ehlers-Danlos Syndrome Diagnosis   Brain & Life Podcast Episodes on Similar Topics Parenting and Writing While Disabled with Jessica Slice Outdoors Woman Crystal Gail Welcome on Nature and Chronic Pain Author Samantha Lee Schmall on Life Beyond the Shunt   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media Guests: Sabina Nordqvist @nordqvistbooks; Dr. Cutsforth-Gregory @mayoclinic Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

Developed by the AUA Residents and Fellows Committee, each episode of the Training Transformed podcast series features an interview with a urology faculty member and resident physician surrounding an innovative facet of resident education at their institution. Tune in for our sixth episode as moderator, Dr. Kayla Graham, chats with Dr. Abhinav Khanna and Dr. Britney Honda about the surgical video review program at the Mayo Clinic Department of Urology in Rochester, Minnesota.

Losing weight on Ozempic, Wegovy, or Mounjaro but feeling bloated, constipated, and miserable? There's a reason, and a new Mayo Clinic study finally proves it.76% of patients on GLP-1s tested positive for SIBO. 91% had methane overgrowth. Dr. Kenneth Brown breaks down why these drugs turn your small intestine into a swamp, why your microbiome decides if the drug even works, and the exact protocol to fix it without quitting the medication.If you're on a GLP-1 or thinking about it, watch this first.

In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Cheryl Bushnell, MD, MHS, who served as the guest editor of the June 2026 Cerebrovascular Disease issue. They provide a preview of the issue, which publishes on June 3, 2026. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Bushnell is a Professor of Neurology and Director of the Center for Transformative Stroke Care at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @CBushnellMD  Full episode transcript available here Dr Jones: One of the core tenets of our field is that we learn neurology one stroke at a time. But what do we have to learn about preventing them altogether? The science of stroke prevention, acute treatment, and recovery are evolving rapidly, and it's hard to keep up. Today, we're speaking with Dr. Cheryl Bushnell, guest editor of our latest Continuum issue on Cerebrovascular Disease, to discuss these topics and much more.  Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast.  Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr. Cheryl Bushnell, who is Continuum's guest editor for our latest issue on Cerebrovascular Disease. Dr. Bushnell is a professor of neurology and the director of the Center for Transformative Stroke Care at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where she specializes in the care of stroke patients and their social and functional determinants of recovery and health, and is an internationally recognized expert on those topics. Dr. Bushnell, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners?  Dr Bushnell: Absolutely. Thank you for the invitation. It's really an honor to be here. So, as you mentioned, I am the director of the Center for Transformative Stroke Care at Wake Forest. It's a really fun transition for me to be involved with different care models for stroke, and I think a lot of the Continuum topics are directly relevant to some of the things that I'm doing now as an administrator and sort of a facilitator of new research. So, thanks again for having me.  Dr Jones: Yeah, and, and you have a wonderful perspective, and we're gonna pull that out today in our interview questions, and I'm looking forward to sharing that with our listeners. But before we get to the questions, we're gonna start off today's podcast with another Continuum Audio trivia question for our listeners. Anticoagulation has played a critical role in secondary ischemic stroke prevention for a long time now. While direct oral anticoagulants have taken on a greater role in the treatment of prevention of stroke, there are still some use cases for vitamin K antagonists like warfarin. The trivia question for our listeners is this: How was warfarin discovered, and how did it get its name? Stick around and we'll share the answer to that question toward the end of our interview today. So, Dr. Bushnell, let's get right to it. You alluded to your various roles, and your leadership in the field has been exemplary. The interventions for acute ischemic stroke have really exploded over the last decade or so, and they get a lot of attention and discussion, but prevention and recovery are just as important in the care of these patients. Tell us a little more about how you approached this issue, about the article topics you chose, etc.  Dr Bushnell: Well, once I was chosen to lead the guest editorship, I wanted to come up with a group of topics that were maybe a little bit different from previous issues. So, I kind of looked at the previous issues and saw, as you said, an emphasis on acute stroke, and that's really important because it has been evolving. But my thought was, how about what happens to patients after they get the intervention and they're discharged home? And because a lot of trainees may not get to see these patients ever again, or it's months before they might see them, or if they're readmitted, which is what we don't want to see, but that certainly is a lot of the exposure is in the inpatient setting. So, I thought I would kind of transport the education into the outpatient and transitional setting, as well as prevention, not only secondary, but primary prevention, with an emphasis on brain health. Some of the populations that may not get as much attention. So, sex differences, stroke in women, pregnancy, the transitions of care, and also the emphasis on holistic view of patients and their challenges, which includes the non-medical factors that drive health, otherwise known as social determinants of health.  Dr Jones: I appreciate that perspective, and obviously th-this is an area of your deep expertise, and it's great to have an issue that really digs into some of those topics a little more deeply. As an educator, I'm really glad you mentioned that about the trainee's perspective. You know, especially junior neurology trainees that are in the hospital all the time. They're seeing patients in the middle of a cerebrovascular catastrophe. But there's a long tail of recovery, right? And they'll get to see that in continuity clinic, but it's a good message to share from an evidence and, um, experiential perspective in the issue. So, appreciate that perspective. You've just read all these articles and edited them. Was there anything that you ran across that was a surprise to you?  Dr Bushnell: Well, I personally chose a lot of the authors based on my knowledge of their work. So, I wouldn't say that it was completely surprising, but I do think that I was just genuinely impressed with the quality of the writing and the synthesis of information. I just was incredibly proud of the work that these co-authors have put together. I'd say that that was-- it wasn't surprising so much as just a sense of pride that I had with the product that's coming out. But of course, there have been some new trials that had to be incorporated at the last minute, some of which were presented at the International Stroke Conference just a few weeks ago.  Dr Jones: Yeah. We try to be as up-to-date as we can, and I will completely agree with you. We have some really good writers in our field, and it's really just a pleasure when you read an article that's by an expert, and it's a joy to read. I can tell you it's one of the best parts of this job, and you get to learn a lot. I think one of the more challenging scenarios that I hear about from colleagues in recent years has been optimal management of patients with asymptomatic extracranial atherosclerosis. The pivotal trials that inform how we manage those patients were from a long time ago, decades ago, predating a lot of the more intensive medical management tools that we have today. In that scenario, Dr. Bushnell, what's the latest on that, and what should our listeners know?  Dr Bushnell: Well, obviously, the CREST 2 trial has been long awaited. It's been going on for over ten years, I believe. Of course, it's, uh, two different trials all in one, the carotid stenting and angioplasty versus intensive medical management. And of course, each of the carotid vascularization arms of the trial also had intensive medical management. And then the other trial is the carotid endarterectomy as the form of revascularization. And it interestingly did not show any benefit of carotid endarterectomy compared to intensive medical management. But of course, the somewhat surprising result was that carotid angioplasty and stenting truly was superior, although it was a small number of events in the trial overall. But that stenting plus intensive medical management was somewhat better than intensive medical management alone. And I think stenting has come a long way in terms of safety, and so I think that's been part of the evolution of the field. I do wanna say that I'm a huge fan of the intensive medical management, and I think that what the protocol does in terms of blood pressure management, cholesterol management is very much above and beyond what's done in private practice even. And the health coaching for all the other things related to diabetes and weight loss and smoking cessation and physical activity, that is what we need to be doing to actually decrease the risk of stroke, and I think that it's very effective. I can't say enough about the design of the study for that reason, that everyone gets the intensive medical management, and then you just layer on the type of revascularization on top of it. So, I wouldn't have been surprised if this was a completely negative trial overall. They just happened to have some better outcomes in the stenting arm.  Dr Jones: I recall a few years ago when the series of endovascular therapy trials for acute stroke came out, and I think there was a, a period of time where the field had to adapt to that. I wonder what you think about with the CREST 2 findings on stenting. I mean, is that gonna be a big change? Because obviously atherosclerosis is highly prevalent. Is that gonna be a big change? Is the field ready for that? How much adjustment do we have in store?  Dr Bushnell: I'm not sure it's gonna be a really big change. If you read the editorial that accompanied the trial in the New England Journal, just a few patients in either direction would have changed the outcome. I kind of look at it as an absolute difference that's relatively small. So, I'm not sure that it will have a huge impact on the field. I do think that the specialists who insert the stents may have some differences of opinion of who should be stented and who shouldn't. Because I think, you know, all of the specialists who do procedures were involved with the trial. But I would say there's a larger percentage of vascular surgeons who were involved, and so I'd say they may have a change of their practice. And neurologists may not even get involved at all.  Dr Jones: Right.  Dr Bushnell: That was one of the challenges for getting patients in the trial is that, you know, not all of us see the asymptomatic carotid stenosis, that they tend to get referred to vascular surgery. So, I think maybe in a corner of the practices of vascular surgeons is where you might see the differences.  Dr Jones: Your point about the way the trial was designed or the trials were designed, that intensive medical management is really important, and we have huge gaps in that. In our specialty, it's, you know, we have probably an opportunity in primary care even to address that. And that leads me to my next question. You know, given your perspective and your expertise, what do you think is the biggest practice gap in the care of patients with stroke or with cerebrovascular disease of any kind?  Dr Bushnell: I think by far the biggest gap is transitions of care and access to follow-up in a specialty clinic after discharge and continuous secondary prevention. We only call it secondary prevention because it happened to come after a stroke, but I really feel like we should just focus on prevention and call it that. There are a lot of people who are trying to kind of, get us away from primary versus secondary prevention. And, and Mitch Elkind is phenomenal and had a beautiful chapter weaving in prevention and brain health. So, I highly recommend that people, if they don't read any other chapters of the Continuum to read his, because I think that it's getting to your point about where the gaps are, and I think prevention is the biggest one. I think we could do so much more in models of care to ensure that there is a pathway once patients are discharged. We have no quality metrics. We have no measurement of how well people are doing after they're discharged. We have all of these fancy things and sophisticated acute treatments, but all of those are for naught if somebody goes home and they fall and they have a severe head injury or hip fracture because they weren't properly supervised or they didn't have the help that they needed at home. So, you got me on my soapbox here for a second, but that is definitely what I see as the gap.  Dr Jones: That's an important soapbox, an important gap, and obviously, if it was a simple problem, we could solve it. But it's obviously something that education is a valuable tool for that, and that's part of why we are including so much content in this issue of Continuum. So, if we put that aside as a gap that we would love to close, when you look into the near future or distant future, Dr. Bushnell, and what's the next big thing on the horizon? New interventions, new prevention tools, or something else entirely? What do you think?  Dr Bushnell: There are two things that I would mention. One is sort of the new category of anticoagulants, antithrombotics, the factor XIa inhibitors. We had an amazing presentation of the oceanic stroke trial at the International Stroke Conference, and this is probably going to be a game changer for the arsenal of antithrombotic therapies that we can offer to patients that do not have a reason for anticoagulation. So, they, they don't have atrial fibrillation, for example, or something else that requires anticoagulation. And so, the factor XI, asundexian, is the drug that they used in that trial. The safety profile is pretty amazing. There was very little bleeding complications and a great benefit in those patients with some degree of atherosclerosis, but, you know, of course, not enough to require carotid revascularization, but then also, um, small vessel disease and cryptogenic stroke. I think those are the three categories of patients, and that's a lot of the strokes that we see all benefited from this new drug. So, I think that's gonna be exciting. There, of course, it has to go through the FDA approval process, and so it might take a little bit of time before that's on the market, and we don't know how much it's gonna cost, but I think it is a, a major breakthrough. And of course, there are other similar medications in that category that are coming. And then I think the other thing is the emphasis on brain health and lifestyle factors and the things that we can do to prevent stroke and dementia because they are the same, essentially. Those are really important. And when we have someone in the hospital with a stroke or a TIA in particular, it's a great teaching opportunity for those patients to say, "Hey, here's what you can do to protect your brain." These are things that we always tell people to prevent a stroke, but just think about it as protecting your brain and keeping your brain as healthy as possible.  Dr Jones: That's a great message, and one that you get to share with patients directly. You're joining us today for this interview. You're on stroke service, so you're actively involved in caring for patients with stroke. What in your practice is the most rewarding aspect of caring for these patients? What is it that you find most rewarding?  Dr Bushnell: I've been involved in a clinical trial that has focused on managing blood pressure and also coaching and other aspects of stroke recovery. I think that has probably been the most rewarding aspect of my career. Until I was involved with this trial, I didn't necessarily do intensive blood pressure monitoring, but I'm seeing the benefits of having data from home, what those blood pressures are over a span of time. I see the immediate or intermediate effects of the blood pressure medication changes that I've made, and I see how the patients respond. So, I have to say that this is not part of usual practice, but I think it should be. And I think it's been incredible from the perspective of a neurologist who is really intensively trying to make the patients' lives better. And it's not just what I do, it's what the health coaches do as part of this intervention. And again, very similar to intensive medical management. So, I, I feel like I've been living it in a slightly different setting than in the CREST 2 trials. But there are other trials that have used the intensive medical management as approach as well. But I would say that's the most rewarding. I've seen people who've lost weight, who are physically fit, who are able to get off of blood pressure medications practically by the end of six months, and that's amazing. And then they continue doing it because they see the benefits.  Dr Jones: You've had a front row seat to a lot of that. That's really got to feel rewarding.  Dr Bushnell: It is, absolutely.  Dr Jones: You know, when you put it that way, it makes me want to go home and check my blood pressure, which I haven't done in a while. But I think that's a message to all of our listeners that we do have plenty of opportunity for risk factor optimization and following the evidence that has been generated and is being generated. Huge opportunity, not only at the population level, but I think the, um, individual patient level too. Okay, so now we're back to our Continuum Audio trivia question, and I'll repeat it for our listeners. How was warfarin discovered, and how did it get its name? Dr. Bushnell and I were talking about this earlier, so I'll just go ahead and share the answer. So, in the early 20th century in the U.S. Midwest, there were epidemics of a hemorrhagic disease in cattle, of all places, and this was eventually traced to moldy cattle feed that was made from sweet clover. And in 1940, researchers at the University of Wisconsin discovered that the anticoagulant in the sweet clover was a compound that was later synthesized for therapeutic use in 1954 as warfarin. And the name came from, uh, the support for the research. The research support came from the Wisconsin Alumni Research Foundation, or WARF, and the end of the word came from the underlying compound, which was coumarin. So that was a little bit of trivia that I had never heard. It's not in the issue, everyone, so you're getting something extra here on the podcast. But been using the drug forever. It still has its uses, even though it's become less advantageous than some of the newer agents. But-- And of course, Dr. Bushnell already knew that when I brought it up, but I just thought that was an interesting bit of history. Well, Dr. Bushnell, thank you for joining us. Thank you for such a great conversation about the latest in cerebrovascular disease. I learned a lot today. I learned a lot in reading these wonderful articles. I hope our listeners learned a lot today as well. I'm really grateful for your hard work on the issue, which I think will come in handy for junior readers and subscribers, as well as our more experienced neurologists as well. Sometimes it's hard to keep up with a rapidly changing subspecialty of our field. So, thank you for joining us today.  Dr Bushnell: Thank you for having me. It's been my pleasure.  Dr Jones: Again, today we've been speaking with Dr. Cheryl Bushnell, guest editor of Continuum's most recent issue on cerebrovascular disease. Please check it out, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.

On tonight's show, I'm joined by Steffenie Jenkins as she shares the story of her 21-year-old son, Jacob, and the medical battle that has changed their family's life. After years of unanswered questions, Mayo Clinic diagnosed Jacob with Bronchiolitis Obliterans, a rare and irreversible lung disease. More recently, doctors determined the condition was likely caused by rheumatoid arthritis affecting his lungs, an extremely rare complication. Now, Jacob continues treatment while facing the possibility of a lung transplant in the future. This is a conversation about a mother's determination, a young man's courage, & a family's fight to hold onto hope through unimaginable challenges. Real stories. Real people. Real impact. News That Unites!™️

On this Make A Difference Minute, I have Steffenie Jenkins sharing the journey she and her family have faced as they searched for answers for their son, Jacob. Now 21 years old, Jacob is battling bronchiolitis obliterans, a rare and irreversible lung disease, and is receiving treatment through Mayo Clinic in Arizona. As Jacob's health declined, Steffenie found herself in a position many families know all too well. She could see something was wrong, yet finding answers proved difficult. Through countless appointments, tests, setbacks, and frustrations, she continued advocating for her son and pushing forward when it would have been easy to give up. Her message is one of perseverance, determination, and trusting your instincts when someone you love is suffering. Sometimes the path to answers is longer than it should be, but Steffenie's story is a reminder of the power of persistence and a mother's unwavering love for her child. If you would like to support the Jenkins family, visit GoFundMe and search “Jacob's Fight to Breathe: Help Us Continue His Care.” You can also email Steffenie at SteffenieJenkins@gmail.com for other ways to support. This MADM is brought to you by Bama Estate Planning by Attorney Harlan D. Mitchell, proudly supporting stories and the people who make our communities strong. Real stories. Real people. Real impact. News That Unites!™️

Host: Darryl S. Chutka, M.D.  Guest: Benjamin Lai, M.D.  Substance use disorders are chronic and often relapsing conditions associated with compulsive substance use. They result from a complex interaction of chemistry within the brain, often combined with genetic and environmental issues. Common substances involve alcohol, stimulants, sedatives and opioids; opioids commonly prescribed by health care clinicians. Early identification of patients and care coordinated with behavioral health specialists is the best approach to improved patient outcomes. The topic for this podcast is “Addiction Care and Empowering Non-Specialists”, and my guest is Dr. Benjamin Lai, A Family Medicine physician from the Department of Family Medicine at the Mayo Clinic.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Sig Muller is an author, motivational speaker, consultant, and founder. He was on the swimming team at Northwestern University in Illinois, where he earned his Bachelor's Degree in Industrial Engineering; following, he received his MBA from the Tuck School of Business at Darmouth in New Hampshire. His career includes leadership roles at Accenture, Ben & Jerry's, Mayo Clinic, UnitedHealth Group General Mills, and multiple startups. In 2024, he survived a sudden cardiac arrest that reshaped his mission, which led him to write and publish "Dying to Be the World's Best" in 2025. Sig makes his home in Minneapolis, Minnesota. 

Menopause Management In Women with Cardiovascular Disease   Guest: Chrisandra Shufelt, M.D. Host: Marysia Tweet, M.D., M.S.   Listeners of this episode of “Interviews with the Experts” will gain a practical, evidence-based framework for managing menopausal symptoms in women with cardiovascular disease or elevated CVD risk. Through discussion of patient selection, menopause-specific cardiovascular risk factors, and the evolving data on hormone therapy. Listeners will leave better equipped to individualize care and counsel patients with confidence.   Topics Discussed: Treatment for menopause symptoms in women with risk factors for CVD  Appropriate candidates for hormone therapy Which cardiovascular risk factors are attributable to ovarian aging (menopause) versus chronological aging? What does the current evidence show regarding claims that menopausal hormone therapy prevents cardiovascular disease? How might the FDA's removal of the black box warning from menopausal hormone therapy labeling affect clinician prescribing practices and patient decision-making?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 15-January-2026

It's Friday, May 29th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus and Jonathan Clark 180 Christian families denied communal water in India More than 180 Christian families in 32 villages across Chhattisgarh State in central India have reportedly been denied access to communal water sources and livelihood opportunities for the past three weeks as punishment for refusing to leave their Christian faith, reports International Christian Concern. Many Christian families in the Antagarh region of the district have been barred from using community rivers, ponds, taps, and hand pumps. At the same time, Christians have been denied work under a government employment scheme.  2 Timothy 3:12 says, "Indeed, all who desire to live a godly life in Christ Jesus will be persecuted." According to Open Doors, India is the 12th most oppressive country worldwide for Christians. Trump's accelerating squeeze on Cuba The Trump administration is bracing for the potential collapse of Cuba's totalitarian government as early as this summer, and has war-gamed new military response plans in case the island descends into chaos, reports Axios. President Trump will keep pushing economic sanctions to try to strangle the regime in Havana in a slow-motion constriction. This methodical squeezing of Cuba's communist regime is also designed to buy time for Trump — who's now engrossed in peace talks with Iran — to eventually focus on Cuba and decide how to bring about change there. The Cuba operation aims to eliminate Latin America's source of Marxist agitation and anti-U.S. activism ever since Fidel and Raul Castro led their successful revolution in 1959. To bring Cuba to its knees this year, the administration first focused on the island's lifeline: Venezuela, which is 1,200-miles south, and its socialist dictator, Nicolás Maduro. Venezuela kept Cuba afloat with shipments of oil that helped power the country and gave it a source of export revenue. Former Attorney General Pam Bondi has thyroid cancer Former U.S. Attorney General Pam Bondi was diagnosed with thyroid cancer shortly after her departure from office earlier this year and is now receiving treatment, reports USA Today. Bondi, age 60, was fired by President Donald Trump in April but is set to return to the Trump administration to serve on an advisory committee on artificial intelligence policy as she battles cancer. Thyroid cancer results from malignant cells growing in a person's thyroid gland, the butterfly-shaped gland at the base of your neck that makes hormones, according to the Cleveland Clinic and Mayo Clinic. These hormones regulate how your body uses energy, including metabolism, heart rate and blood pressure. Jill Biden wondered whether Joe had a stroke mid debate Remember this pivotal moment in the 2024 presidential debate between Joe Biden and Donald Trump? BIDEN: “Making sure that we continue to strengthen our health care system. Making sure that we're able to make every single solitary person eligible for what I've been able to do with the uh, with the COVID, excuse me, with, um, with dealing with everything we have to do with.  Look, if.  We finally beat Medicare!” As First Lady Jill Biden watched her husband stumble through the most cringeworthy portion of his disastrous June 2024 debate, she wondered if he had unknowingly ingested drugs or was having a medical episode on live television. In an upcoming CBS News Sunday Morning interview she said this. JILL BIDEN: “As I watched it, I thought, ‘He's having a stroke!' And it scared me to death.” However, at the time, right after the debate two years ago, Jill Biden said this. JILL BIDEN: “Joe, you did such a great job! You answered every question. You knew all the facts.” In her new biography entitled, View From the East Wing, she was far more candid. She wondered, “Is he short-circuiting? Is this a stroke? I felt like we were watching an AI hologram of the man we knew, and the hologram was glitching. Has he been drugged?” According to The Atlantic, which has seen a preview copy ahead of the June release, Jill Biden wondered, “Will people watching assume this is how he is all the time?” Bidens fighting to squelch embarrassing audio recordings Gary Bauer, founder of American Values and the co-host of Family Talk, wrote, “Right now, the Bidens are fighting to prevent closed-door audio recordings of interviews Joe Biden did from being released to the public. Why? Because in those interviews Biden couldn't remember basic events in his life. He couldn't remember when he was vice president. He couldn't remember when his son, Beau, died. He couldn't remember the advice his generals gave him.”   Bauer concluded, “And we all remember what Special Counsel Robert Hur said. Hur did not charge Biden for keeping classified documents because no jury would convict an ‘elderly man with a poor memory.' In other words, Joe was not mentally competent to stand trial.” Teenage worker bees drops to lowest level since 1948 The number of teenagers working jobs this summer is expected to fall to the lowest level since 1948. The consulting firm Challenger, Gray & Christmas predicts teens will gain 790,000 jobs in May, June, and July. That's down from 801,000 last summer. The firm noted, “Rising inflation, climbing oil prices, and a broadly cautious hiring environment are expected to keep the 2026 summer hiring total well below historical averages as employers and consumers rein in spending.” Welsh preacher John Penry pleaded for Welsh evangelism before execution And finally, on May 29,1593, 433 years ago today, Welsh Protestant preacher John Penry appealed for Christian pastors to proclaim the Gospel of Jesus Christ in Wales shortly before his execution under the reign of Queen Elizabeth I. John Penry wept for Wales. He noted that thousands of Welsh had never heard of Christ. He wrote, “O destitute and forlorn condition! Preaching itself in many parts is unknown. In some places, a sermon is read once in three months.” Penry proposed a system of lay pastors supported in part with voluntary gifts from the people. His attack on the neglectful behavior of the Church of England won Penry the undying hostility of John Whitgift, the Archbishop of Canterbury, reports the Christian History Institute. Having become a Puritan Separatist in his thinking, Penry could not accept a state-run system because, "The truth of Christ” could not be in bondage to an “anti-Christian power.” Because of such outspoken views, and his stern warnings to Queen Elizabeth I and her bishops, Penry had to flee. Because he dared to expose the Church of England for its neglect, John Penry was captured and treated to a travesty of justice. Some strong words of warning against the queen in his notebook were interpreted as treason. Archbishop Whitgift was the first to sign his death warrant. Penry was hauled off to be hanged on this day, May 29, 1593. A thin scattering of bystanders, none of them his friends, watched as the 34-year old departed this world at the end of a rope about four in the afternoon. He was not allowed to preach a final sermon. He had, however, written a lengthy letter to his four daughters named Deliverance, Comfort, Safety, and Sure Hope -- who ranged in age between 4 and four months. He implored them to follow the true faith. James 1:12 says, “Blessed is the one who perseveres under trial because, having stood the test, that person will receive the crown of life that the Lord has promised to those who love Him." Close And that's The Worldview on this Friday, May 29th, in the year of our Lord 2026. Subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

"There are a lot of specifics that nurses need to keep in mind as they are administering this herpes simplex modified virus to patients because accidental exposure is of concern both to the patient, to their family members, as well as to healthcare workers. I always recommend nurses wear personal protective equipment, such as a gown, safety glasses, gloves, and/or a face shield," Heidi Finnes, PharmD, RPh, BCOP, director of clinical ambulatory practice at Mayo Clinic and assistant professor of pharmacy at Mayo Clinic Alix School of Medicine in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about oncolytic viral therapy.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 29, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of oncolytic viruses to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 273: Updates in Chemotherapy and Immunotherapy ONS Voice articles: Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy Oncolytic Virus Kills Tumor Cells While Supporting T Cells What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma Clinical Journal of Oncology Nursing articles: Intralesional Therapy: Consensus Statements for Best Practices in Administration From the Melanoma Nursing Initiative Safe and Effective Standards of Care: Supporting the Administration of T-VEC for Patients With Advanced Melanoma in the Outpatient Oncology Setting Oncology Nursing Forum article: Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma ONS book: Guide to Cancer Immunotherapy (second edition) ONS clinical practice resource: Safe Handling of Oncolytic Viruses ONS Huddle Card: Immunotherapy Association of Community Cancer Centers (ACCC) Drugs@FDA Hematology/Oncology Pharmacy Association (HOPA) Network for Collaborative Oncology Development and Advancement (NCODA) Patient Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "[Oncolytic viruses] can have direct lysis to the tumor cells themselves, or they can cause immunogenic activation. They release tumor-associated antigens and then proinflammatory signals, so think of T cells, natural killer cells, those sorts of things, that can convert to immunologically cold tumors. Those are tumors that are immune silenced into hot tumors which are now immune activated. By doing that, they recruit those T cells and other cells to the area to attack both the primary tumors. But that's also thought to be how they work on distant or noninjected sites as well. This immunomodulatory capacity has led to the reclassification of oncolytic viruses as a form of cancer immunotherapy. So, think of it kind of similarly to how we think of immune checkpoint inhibitors in recruiting immune cells and leaving our immune system in the on position. This is also kind of a form of immunotherapy." TS 4:35 "One of the toxicities I know that is of significant concern to patients, family members, and healthcare workers is the incidence of herpes infections. Systemic herpetic infections are extremely rare and usually more common in patients who may be immunocompromised. In patients who also have other immune-related diseases—such as vitiligo, vasculitis, pneumonitis, sometimes worsening psoriasis—because you're mounting an immune response with these types of things, sometimes you can see a worsening of those types of immune symptoms. But for the most part, these types of side effects are very well tolerated in most patients." TS 9:07 "Talimogene is generally transmitted via bodily fluids or touch. It's not airborne. Herpes simplex virus isn't an airborne type of virus. Another thing to consider is where are you going to inject this? Are you going to do this in your infusion therapy unit? Are you going to do it in a dedicated room? Who's going to escort the patient to the room? How is the virus going to arrive at the room? How will you clean the room and all of the laboratory equipment or any of the exam tables that may be in there? I think having all of that discussed and assigned mitigates the consternation that can sometimes occur—the fear that occurs with administering a virus that is thought to be fairly communicable." TS 15:44 "Helping patients understand how this works [is important] because hearing that you're receiving a virus, particularly a herpes simplex virus, can be scary to a patient. I think understanding that it's modified or essentially we're taking the parts out of it so that we can directly inject a portion that recruits immune cells to that area, because the goal is for the oncolytic virus to attack cancer cells and then destroy them by triggering an immune response in the body." TS 20:51 "Sometimes patients are very concerned about urine in the toilet, bodily fluids, kissing loved ones, holding hands, hugging, you know, am I going to infect my loved one because I'm getting this type of an oncolytic virus therapy? I like to reassure patients that they can continue to hold hands and hug their loved ones as normal. Viral DNA is usually only present on the injection site. And as I mentioned previously, we want to cover that injection site with an occlusive dressing, at least with talimogene, for up to seven days. And particularly, if those injection sites are at all oozing or weeping, active virus is usually only on that injection site itself." TS 24:14

Our great friend Bill Morice, the Mayo Clinic Big Knocker, was in town for a meeting so he stopped by the studio for over an hour of great discussion on a wide-range of health care topics. See omnystudio.com/listener for privacy information.

Our great friend Bill Morice, the Mayo Clinic Big Knocker, was in town for a meeting so he stopped by the studio for over an hour of great discussion on a wide-range of health care topics. See omnystudio.com/listener for privacy information.

Your skin has a biological age and for most people, it's not the same as their chronological one. Mayo Clinic published the SkinSpan framework this year specifically to quantify it, and the 12 Hallmarks of Aging now have a direct application to dermal tissue.This raises an uncomfortable question: if you're already optimizing everything below the neck with NAD IVs, peptides, and red light, why is the skincare on your face still operating on a paradigm from 1987?In this new episode of the Biohacking Beauty Podcast, we give you a preview of the keynote we're delivering at Dave Asprey's Beyond Conference and walk you through the 3-pillar framework that replaces traditional anti-aging skincare with longevity science in mind.Because the results you can feel today and results you can measure in ten years are not the same thing. And we think you deserve both.Let's dive in.What's Discussed:(2:29) The gap no one in longevity talks about.(3:06) Why your moisturizer is 38 years behind your supplements.(6:21) The 12 Hallmarks of Aging, decoded.(9:42) Pillar 1: The master pathway of skin aging.(12:18) Why NAD in a jar doesn't work (and what does).(14:22) The cellular housekeeping system that quietly shuts down with age.(15:17) The peptide that affects 32% of your skin's genome.(16:55) Pillar 2: The software updates your cells stop sending.(20:09) The PRP lineage that changed regenerative aesthetics.(22:54) Pillar 3: The pillar our community doesn't want to hear about.(29:09) The protocol, tiered by where you're starting.(37:55) How Young Goose fits into what you're already doing.(40:32) The two tests we're building to measure skin longevity.Find more from Young Goose:Use code PODCAST10 to get 10% off your first purchase, and if you're a returning customer use the code PODCAST5 to get 5% off at https://younggoose.comInstagram: @young_goose_skincareHead to younggoose.com/products/youth-body-cream for 20% off

Photo courtesy Great Lakes Indian Fish and Wildlife Commission / Facebook All eleven federally recognized tribes in Wisconsin have seats on a new committee aimed at protecting wild rice. Chuck Quirmbach reports. Gov. Tony Evers (D-WI) has announced his 24 appointees to the Wild Rice Stewardship Council. One member, Gloria Waabigwan Wiggins (Bad River Band of Lake Superior Chippewa), works for the group Wisconsin Native Vote. Wiggins also keeps up a tribal tradition, protected by a 1983 federal court ruling, of gathering wild rice in the ceded territory of Northern Wisconsin. “I’ve been harvesting wild rice, manoomin, with my husband for say, the last 9-10 years. Our powwow, our celebration of manoomin, is in August. So that’s a very important event for our community.” Wiggins says wild rice is also part of a sacred migration story for the Anishinabe, Indigenous people of the Great Lakes region. But tribal and state officials report low production of wild rice in recent years, due to factors like windstorms and very heavy rainfall, and long-standing threats like water pollution and excessive waves from boats. Another member of the new Stewardship Council, Eric McLester, helps direct environmental policy for the Oneida Nation. He says the big picture concern is climate change. “The amount of rain, water levels. It’s important to not have huge increases or decreases in water levels. Drought certainly impacts the wild rice beds.” McLester says the Oneida have restored about 35 acres of wetlands for wild rice production in recent years. He hopes the tribal members on the wild rice council can share best practices for the resource. It’s also possible the committee will propose new regulations to protect wild rice. A First Nations family in Canada is demanding answers after 24-year-old Jaali Sutherland-Weenie died during childbirth after reportedly being diagnosed with pre-eclampsia while 36 weeks pregnant. Family members say Sutherland-Weenie, from Beardy's and Okemasis’ Cree Nation in Saskatchewan, sought medical care in the days leading up to her death and raised concerns about symptoms linked to the dangerous pregnancy complication. According to the Mayo Clinic, pre-eclampsia causes high blood pressure during pregnancy and can quickly become life-threatening for both mother and baby if not closely monitored and treated. According to relatives, Sutherland-Weenie first went to a hospital in Rosthern before being transferred to Jim Pattison Children's Hospital and later to the labor and delivery unit at Royal University Hospital in Saskatoon, where she died on April 26 after giving birth to her daughter. Her death is now drawing attention from Indigenous advocates and community members who say Indigenous women continue to face inequities in maternal health care and are too often dismissed when reporting pain or complications. Loved ones are calling for accountability and a full review into what happened. Community members have also taken to social media to share condolences and call for better protections for Indigenous mothers navigating the health care system. The Saskatchewan Health Authority says a review is underway. Blayne Morin, Sutherland-Weenie's partner, said during a news conference held at Wanuskewin Heritage Park in Saskatoon, Saskatchewan earlier this week, he plans to attend her graduation ceremony next month to accept her degree on her behalf. Morin says the couple wanted to build a better life for their daughter than the ones they experienced growing up. “The family and I will be attending her congregation next month, taking her degree, and we planned so much for our baby before she made her appearance here. We didn't want her to grow up like how we did, breaking the intergenerational trauma.” Sutherland-Weenie leaves behind a newborn daughter and a grieving family now hoping her story raises awareness about the warning signs of pre-eclampsia and the importance of timely medical care. Get National Native News delivered to your inbox daily. Sign up for our daily newsletter today. Download our NV1 Android or iOs App for breaking news alerts. Check out today’s Native America Calling episode Thursday, May 28, 2026 — Exploring home, culture, and personal resolve with writers Joan Kane and Sherman Funmaker

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, speaks with William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, about Ebola, hantavirus and takeaways from a recent healthcare conference. Later, she welcomes Elli Theel, Ph.D., a microbiologist in Mayo Clinic's Department of Laboratory Medicine and Pathology, to explore vector-borne diseases.Top industry topics (00:04): Dr. Morice highlights key topics from a recent major healthcare conference, including AI and payment reform.Infectious diseases in the news (04:04): Overview of hantavirus, Ebola, and why laboratory medicine is important during outbreaks. Growing prevalence of vector-borne diseases (06:48): Insights on the growing prevalence of vector-borne diseases.Testing options (09:45): Understand the different types of testing available for pathogens and when it is best to use each one. Innovation and discovery (17:05): Discover emerging pathogens and advances in detection.Protect yourself (19:41): Learn easy ways to protect yourself and your family from vector-borne diseases. Note: Information in this post was accurate at the time of its posting.ResourcesForbes: Is hantavirus an emerging threat? What you need to knowVector-borne diseases by geographic regionVector-borne diseases: The right tests for detection and diagnosisLearn the ABCs of ticks

Host: Darryl S. Chutka, M.D.  Guest: Michael Mueller, M.D.  Fibromyalgia is a chronic health problem commonly seen in a primary care setting. It can be challenging to diagnose and even more so to manage. It can have a devastating effect on a patient's lifestyle, and patients will commonly go from provider to provider seeking relief for their chronic symptoms. We now have a better understanding of the pathophysiology of fibromyalgia; unfortunately, the treatment remains less than optimal. What do we know regarding the cause of the symptoms in fibromyalgia? How can we efficiently establish a diagnosis in patients with the condition without excessive testing? How do we explain the disorder to patients and what's the long-term outlook for patients? These are some of the questions I'll be asking my guest, Dr. Michael Mueller, an internist in the Division of General Internal Medicine at the Mayo Clinic as we discuss “Fibromyalgia”.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Long COVID isn't just lingering fatigue. It's a complex, often life-altering condition that can follow even mild or unnoticed infections. Listen in as Mayo Clinic's Dr. Stephanie Grach breaks down what we really know about Long COVID, who's at risk, and why believing and individualizing care for patients is absolutely critical.   In this episode, Therese Markow and Dr. Stephanie Grach discuss the emergence and impact of Long COVID. Dr. Grach explains that Long COVID affects an estimated 18 million Americans with a wide variety of symptoms that can manifest differently from patient to patient, influenced by a variety of factors, such as viral variant, genetics, and immune responses. Dr. Grach emphasizes the importance of individualized treatment and highlights ongoing research and the need for better understanding and management of this complex chronic condition.     Key Takeaways: Long COVID can look very different from person to person, with over 200 symptoms. However, common symptoms can include fatigue, brain fog, shortness of breath, changes in smell, and more, affecting nearly every organ system.  The larger proportion of people with Long COVID had multiple COVID infections, partly because of sheer numbers - each additional infection is another opportunity for post-acute symptoms to develop or worsen.  The presentation of the Long COVID symptoms is not going to be consistent - patients may have good weeks and feel pretty close to normal, as well as bad weeks, where the symptoms are at their strongest.  Telling someone to "push through" on the assumption that it will just get better really isn't what helps the Long COVID patients.   "Long COVID is real. Patients deserve to be believed, and treatment should be individualized, rather than trying to fit or wait for a one-size-fits-all." —  Dr. Stephanie Grach   Connect with Dr. Stephanie Grach: Professional Bio: https://www.mayoclinic.org/biographies/grach-stephanie-l-m-d-m-s/bio-20536370  LinkedIn: https://www.linkedin.com/in/stephaniegrach    Connect with Therese: Website:  www.criticallyspeaking.net Bluesky: @CriticallySpeaking.bsky.social Instagram: @criticallyspeakingpodcast Email: theresemarkow@criticallyspeaking.net     Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it. 

Rochester is America's City for Health. It's the home of the world-famous Mayo Clinic. Listen to how the mayor of Rochester manages a city with this huge partner. And learn how to move with the mayor. Brought to you by The Good Government Institute, bringing together proven ideas, principled leaders, and real-world solutions to strengthen how we govern—not by reinventing the system, but by advancing what already works. GoodGovernmentShow.com Thanks to our sponsors: HelloNation Ourco Good News For Lefties (and America!) - Daily News for Democracy (Apple Podcasts | Spotify) How to Really Run a City Leading Iowa: Good Government in Iowa's Cities (Apple Podcasts | Spotify) The Context: A Podcast by the Charles F. Kettering Foundation The Good Government Show is part of The Democracy Group, a network of podcasts that examines what's broken in our democracy and how we can work together to fix it. The Royal Cousins: How Three Cousins Could Have Stopped A World War by Jim Ludlow Executive Producers: David Martin, David Snyder, Jim Ludlow Host/Reporter: David Martin Producers: David Martin, Jason Stershic Editor: Jason Stershic

What if you could detect Alzheimer's years before any symptoms appeared and stop it?Dr. Yogesh Shah is a Board-Certified Geriatrician and Mayo Clinic-trained memory specialist who has spent 25 years focused entirely on the early detection and prevention of dementia. In this episode, he makes a case that every entrepreneur in their 40s and 50s needs to hear: the window to protect your brain is now. Not at 70. Not after a diagnosis.America spends 20% of its GDP on healthcare, and nearly all of it goes to disease management. Dr. Shah explains why that approach is failing, what Mild Cognitive Impairment is and why it matters, and how a new FDA-approved blood test can identify Alzheimer's pathology years before any symptoms appear. He walks through the 14 lifestyle factors identified in the Lancet study that can reduce dementia risk by up to 45%, and explains how monoclonal antibody infusions are now removing amyloid plaque from the brains of patients caught early enough.What you will walk away with: an understanding of why 40 to 50% of dementia cases go undiagnosed and the real-world consequences, what the new p-tau blood tests are and how to ask your doctor about getting one, which lifestyle factors carry the most risk weight for entrepreneurs, and why managing your LDL, sleep, social connection, and chronic conditions in midlife is the most important thing you can do for your future brain health.Connect with Dr. Yogesh Shah on LinkedIn Hosted by John St. Pierre and Rich Hoffmann, Entrepreneurs United is built for founders and leaders who want straight talk on building businesses that actually work. New episodes every week.https://entrepreneursunited.us/links/

In this episode of the Chasing Giants Podcast, Don Higgins returns after spending time helping Robin recover from major surgery at Mayo Clinic. Don shares an emotional update on Robin's condition, the road ahead with chemo treatments, and thanks the Chasing Giants family for the overwhelming prayers and support. Terry also recaps an unforgettable Manitoba black bear hunt filled with giant bears, unbelievable footage, close encounters, and stories that will eventually become two full Chasing Giants TV episodes. The guys also dive into: Spring food plot challenges and excessive rain Soybean planting strategies and browse pressure The upcoming “Doubting Thomas” video release Why Scrape Magnet played a major role in Don's success Michigan becoming a one-buck state Supplemental feeding vs baiting Why mature bucks become nocturnal Sanctuary intrusion and fawn survival As always, the show blends faith, deer hunting, land management, and real-life perspective. Please continue praying for Robin and the Higgins family. Sponsors: Asio Gear – https://asiogear.com Real World Wildlife Products – https://realworldwildlifeproducts.com Hawke Optics – https://us.hawkeoptics.com Novix Outdoors – https://novixoutdoors.com Midwest Land Group – https://midwestlandgroup.com 360 Hunting Blinds – https://360huntingblinds.com Mike's Mighty Micros – https://mikesmightymicros.com Gingerich Tree Farm – https://gingerichtreefarm.com TagOut Technique – https://tagouttechnique.com Grubb Implement – https://grubbimplement.com Brenton USA – https://brentonusa.com Mathews Archery – https://mathewsinc.com Victory Auto Group – https://victorykc.com Wildlife Farming – https://wildlifefarming.com WiseEye Technologies – https://wiseeyetech.com DISCLAIMER: The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any sponsors or affiliated companies. © Chasing Giants. All rights reserved. This content may not be reproduced or distributed without written permission.

"When you have benign conditions, we're actually treating 3 gray, so a significant difference [versus doses of 60 gray for brain cancer]. Typically, when you treat at a high dose, the goal is to destroy tissue, like cancer tissue or cancer cells. But when we give a low dose, the goal is actually to modulate inflammation. And what it does is it slows down those inflammatory cells or those cells that release the chemicals that cause pain and inflammation," Amanda Meyer, DNP, APRN, CNP, family nurse practitioner in the Department of Radiation Oncology at the Mayo Clinic in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation therapy for noncancer indications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 22, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of radiation to treat noncancerous conditions. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 365: Radiation-Associated Secondary Cancers Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices ONS Voice articles: Augmented Reality Simulations Reduce Patient Anxiety by Teaching Them About Radiation Therapy Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education Quick Quiz: Test Your Knowledge of Radiation Care Coordination ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS Radiation Oncology Conference Recordings Bundle™ ONS ROCN™ Certification Review™ Radiation Oncology 101: 2024 ONS Bridge™ Session ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Findings From the 2023 Radiation Oncology Nursing Role Delineation Study to Shape the Future of the Subspecialty The Role of Advanced Practice Providers in Radiation Oncology in 2025 ONS Huddle Cards: Radiation Radiobiology German Society for Radiation Oncology (DEGRO): Guidelines in Radiotherapy: Radiotherapy for Benign Diseases To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We always typically think of it as cancer treatment, but we can use radiation for noncancerous conditions, as well. And radiation was actually used for benign diseases right after the discovery of x-rays. By the 1920s it was used a lot for different types of musculoskeletal, dermatologic issues, and different types of inflammatory conditions. And over time, since the 1920s, we've actually really gotten a really good understanding of it." TS 1:37 "When we're looking at what are good candidate characteristics, we do typically like older patients, so patients over the age of 65. And the rationale behind that is we know that there is a potential for a secondary risk of a skin cancer about 20 to 30 years after getting low-dose radiation, like a basal cell or squamous cell skin cancer. The older the patient is, the less likely they are to have any adverse effects from that." TS 8:22 "When we do the low-dose radiation, they've tried other measures that haven't been successful. However, we don't want a patient who is so severe that they're ready for surgery, when they're bone on bone, because we know that radiation isn't as effective when they are that severe. So there's this sweet window where low-dose radiation works best in these patients." TS 9:39 "When we're treating with a little bit higher dose for like a Dupuytren's or a Ledderhose, because it's an anti-proliferative dose, those patients, they do get more skin redness, more dry skin. That's very temporary, and it resolves within a week or two after treatment. But really, we don't see any acute side effects. The long-term side effect of the radiation-induced malignancy, again, is a very low—0.05% according to some of the European guidelines." TS 12:34 "I really wish people appreciated how interdisciplinary this is. We need to get referrals from family medicine and from primary care and internal medicine and pain medicine physicians and inflammatory physicians and podiatry and pain specialists. And we really need to use this multidisciplinary approach to get earlier referrals for patients because there is this sweet window of time where low-dose radiation works the best." TS 18:40

Darshan Shah, MD is a board-certified surgeon, published author, and Founder and CEO of Next Health – the first, largest and fastest-growing health optimization and longevity clinic. He earned his medical degree at the age of 21 from the University of Missouri-Kansas City, becoming one of the youngest doctors in the United States at the time. He continued his training at the Mayo Clinic and earned his MBA from Harvard Business School. As a longevity medicine specialist, he has advised thousands of patients on how to optimize their well-being and extend their healthspan and lifespan. Today on the show we discuss why living longer means nothing if your health span is broken, the biggest mistakes people make when chasing longevity, why most people should focus on metabolic health before biohacking, the blood markers Dr. Shah believes everyone should track, how strength training, walking, sleep, and nutrition protect your future, why ultra-processed foods are quietly wrecking your health, the truth about alcohol, weed, caffeine, fasting, sauna, cold plunge, red light therapy, wearables, supplements, NAD, and how toxins, stress, relationships, and circadian rhythm all impact how well you age. And much more.  Today's sponsor: Fatty15:  Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/DOUG and using code DOUG at checkout Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Darryl S. Chutka, M.D  Guest: Mark D. Tyson, III, M.D., M.P.H.  Bladder cancer is one of the most common malignancies worldwide, and primary care clinicians are often the first to evaluate patients with bladder cancer. The symptoms are usually subtle and may include either gross or microscopic hematuria. The decision in whether to investigate these presenting symptoms can often impact early diagnosis and the patient's outcome. When should we investigate hematuria? What should an evaluation of hematuria consist of? What is the treatment for bladder cancer? How should patients with recurrent bladder cancer be managed? What role does the primary care clinician play in the long-term management of patients? I'll be asking these questions and more of my guest, Dr. Mark Tyson, a urologist at the Mayo Clinic as we discuss “Bladder Cancer”.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development